Literature DB >> 18175951

Synthesis of poly(vinyl alcohol)-doxorubicin conjugates containing cis-aconityl acid-cleavable bond and its isomer dependent doxorubicin release.

Atsufumi Kakinoki1, Yoshiharu Kaneo, Yuka Ikeda, Tetsuro Tanaka, Kahee Fujita.   

Abstract

Aconityl-doxorubicin (ADOX) was synthesized by the modified method of Shen and Ryser. Two isomers of cis-ADOX (cis-configuration) and trans-ADOX (trans-configuration) were generated in the reaction of DOX and cis-aconitic anhydride. These products were separated completely by using HPLC and analyzed by TOF-MS spectroscopy and (1)H- and (13)C-NMR experiments. The yields of cis-ADOX and trans-ADOX were 36.3 and 44.8%, respectively. The free gamma-carboxylic group of ADOX molecule was coupled to poly(vinyl alcohol) (PVA) via ethylenediamine spacer, resulting the macromolecular conjugates of PVA-cis-ADOX and PVA-trans-ADOX, respectively. The DOX content of the conjugates estimated by the hydrolysis method detected the aglycone of DOX which can be estimated as the PVA-bound DOX selectively was 4.4 w/w% which was similar to 4.6 w/w% by the ordinary UV method. Both PVA-cis-ADOX and PVA-trans-ADOX were very stable at neutral pH, but the release of DOX was increased markedly under acidic conditions. Half-life of the release of DOX from PVA-cis-ADOX at pH 5.0 was 3 h which was 4.7-fold shorter than that from PVA-trans-ADOX (14 h). The cytotoxicities of PVA-cis-ADOX and PVA-trans-ADOX were evaluated by using J774.1 cells employing a [(3)H]uridine incorporation assay as a measure of RNA synthesis. A significant difference in antitumor activity between PVA-cis-ADOX and PVA-trans-ADOX was observed where the former was much active than the later. It was suggested that the conjugate enters the cells and reaches the lysosomal/endosomal compartment, and that the aconityl spacer releases DOX from the conjugate in the acidic compartment of lysosomes/endosomes due to the participation of a free carboxylic group.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18175951     DOI: 10.1248/bpb.31.103

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate.

Authors:  Cody P Coyne; Toni Jones; Ryan Bear
Journal:  Cancer Biother Radiopharm       Date:  2011-12-22       Impact factor: 3.099

2.  PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation.

Authors:  Saijie Zhu; Minghuang Hong; Lihong Zhang; Guotao Tang; Yanyan Jiang; Yuanying Pei
Journal:  Pharm Res       Date:  2009-10-28       Impact factor: 4.200

Review 3.  Macromolecular therapeutics.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  J Control Release       Date:  2014-04-18       Impact factor: 9.776

4.  Conjugation of amino-bioactive glasses with 5-aminofluorescein as probe molecule for the development of pH sensitive stimuli-responsive biomaterials.

Authors:  Valentina Aina; Gianluca Malavasi; Claudio Magistris; Giuseppina Cerrato; Gianmario Martra; Guido Viscardi; Ledi Menabue; Gigliola Lusvardi
Journal:  J Mater Sci Mater Med       Date:  2014-04-11       Impact factor: 3.896

5.  Design of a Novel Theranostic Nanomedicine (III): Synthesis and Physicochemical Properties of Tumor-Targeting Cisplatin Conjugated to a Hydrophilic Polyphosphazene.

Authors:  Basavaraj R Patil; Su Yeon Kang; Da Hee Jung; Prakash G Avaji; Yong Joo Jun; Hwa Jeong Lee; Youn Soo Sohn
Journal:  Int J Nanomedicine       Date:  2020-02-12

6.  In vitro and in vivo antitumor activity of a novel pH-activated polymeric drug delivery system for doxorubicin.

Authors:  Menglei Huan; Bangle Zhang; Zenghui Teng; Han Cui; Jieping Wang; Xinyou Liu; Hui Xia; Siyuan Zhou; Qibing Mei
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

7.  Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab.

Authors:  Parisa Yousefpour; Fatemeh Atyabi; Ebrahim Vasheghani-Farahani; Ali-Akbar Mousavi Movahedi; Rassoul Dinarvand
Journal:  Int J Nanomedicine       Date:  2011-09-14

Review 8.  Anticancer nanoparticulate polymer-drug conjugate.

Authors:  Quanyou Feng; Rong Tong
Journal:  Bioeng Transl Med       Date:  2016-10-28

9.  Solid Lipid Particles for Lung Metastasis Treatment.

Authors:  Lourdes Valdivia; Lorena García-Hevia; Manuel Bañobre-López; Juan Gallo; Rafael Valiente; Mónica López Fanarraga
Journal:  Pharmaceutics       Date:  2021-01-13       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.